Relationship between cardiovascular risk as predicted by established risk scores versus plaque progression as measured by serial intravascular ultrasound in left main coronary arteries

Circulation

Volumn 110, Issue 12, 2004, Pages 1579-1585

  Von Birgelen, Clemens ^b,d   Hartmann, Marc ^a   Mintz, Gary S ^c   Van Houwelingen, K Gert ^b   Deppermann, Nadine ^a   Schmermund, Axel ^a   Böse, Dirk ^a   Eggebrecht, Holger ^a   Neumann, Till ^a   Gössl, Mario ^a   Wieneke, Heinrich ^a   Erbel, Raimund ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

^c CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^d Hospital Enschede   (Netherlands)

Author keywords

Coronary disease; Imaging; Prevention; Risk; Secondary; Ultrasonics

Indexed keywords

ADULT; AGED; ALGORITHM; ARTERY DIAMETER; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CLINICAL FEATURE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INTRAVASCULAR ULTRASOUND; LEFT CORONARY ARTERY; LINEAR SYSTEM; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SECONDARY PREVENTION; ULTRASOUND SCANNER; ULTRASOUND TRANSDUCER;

AGED; ALGORITHMS; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMORBIDITY; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERLIPIDEMIAS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SMOKING; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 20844440714     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000142048.94084.CA     Document Type: Article

References (29)

1. Mintz GS, Nissen SE, Anderson WD, et al. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). J Am Coll Cardiol. 2001;37:1478-1492.
2. Takagi T, Yoshida K, Akasaka T, et al. Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin. Am J Cardiol. 1997;79:1673-1676.
3. Shiran A, Mintz GS, Leiboff B, et al. Serial volumetric intravascular ultrasound assessment of arterial remodeling in left main coronary artery disease. Am J Cardiol. 1999;83:1427-1432.
4. Schartl M, Bocksch W, Koschyk DH, et al, for the GAIN-Study Investigators. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation. 2001;104:387-392.
5. Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant apoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes. JAMA. 2003;290:2292-2300.
6. von Birgelen C, Hartmann M, Mintz GS, et al. Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (≥ 12 months) follow-up intravascular ultrasound. Circulation. 2003;108: 2757-2762.
7. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;19:344: 1383-1389.
8. Shepherd J, Cobbe SM, Ford I, et al, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary artery disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333: 1301-1307.
9. Sacks FM, Pfeffer MA, Moye LA, et al, for the Cholesterol And Recurrent Events (CARE) trial investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001-1009.
10. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279:1615-1622.
11. Ballantyne CM. Clinical trials endpoints: angiograms, events and plaque instability. Am J Cardiol. 1998;82:5M-11M.
12. Wood D, De Backer G, Faergeman O, et al. Prevention of coronary heart disease in clinical practice: recommendations of the second joint task force of European and other societies on coronary prevention. Atherosclerosis. 1998;140:199-270.
13. Grundy SM, Pasternak R, Greenland P, et al. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999;100:1481-1492.
14. Fodor JG, Frohlich JJ, Genest JJ Jr, et al. Recommendations for the management and treatment of dyslipidemia: report of the working group on hypercholesterolemia and other dyslipidemias. CMAJ. 2000;162: 1441-1447.
15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
16. Conroy RM, Pyörälä K, Fitzgerald AP, et al, for the SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987-1003.
17. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2003;24:1601-1610.
18. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Mudie;nster (PROCAM) Study [published correction appears in Circulation. 2002;105:900]. Circulation. 2002;105: 310-315.
19. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Mudie;nster (PROCAM) Study [published correction appears in Circulation. 2002;105:900]. Circulation. 2002;105: 310-315.
20. Anderson KM, Wilson PW, Odell PM, et al. An updated coronary risk profile: a statement for health professionals. Circulation. 1991;83: 356-362.
21. Assmann G, Carmena R, Cullen P, et al. Coronary heart disease: reducing the risk: a worldwide view. International Task Force for the Prevention of Coronary Heart Disease. Circulation. 1999;100:1930-1938.
22. Baumgart D, Haude M, Ge J, et al. Online integration of intravascular ultrasound images into angiographic images. Cathet Cardiovasc Diagn. 1996;39:328-329.
23. von Birgelen C, Airiian SG, Mintz GS, et al. Variations of remodeling in response to left main atherosclerosis assessed with intravascular ultrasound in vivo. Am J Cardiol. 1997;80:1408-1413.
24. von Birgelen C, Klinkhart W, Mintz GS, et al. Plaque distribution and vascular remodeling of ruptured and nonruptured coronary plaques in the same vessel: an intravascular ultrasound study in vivo. J Am Coll Cardiol. 2001;37:1864-1870.
25. Smith SC Jr, Blair SN, Criqui MH, et al. Preventing heart attack and death in patients with coronary disease. Circulation. 1995;92:2-4.
26. Grover SA, Paquet S, Levinton C, et al. Estimating the benefits of modifying risk factors of cardiovascular disease: a comparison of primary vs secondary prevention [published correction appears in Arch Intern Med. 1998;158:1228]. Arch Intern Med. 1998;158:655-662.
27. Grover SA, Paquet S, Levinton C, et al. Estimating the benefits of modifying risk factors of cardiovascular disease: a comparison of primary vs secondary prevention [published correction appears in Arch Intern Med. 1998;158:1228]. Arch Intern Med. 1998;158:655-662.
28. Genest J, Pedersen TR. Prevention of cardiovascular ischemic events: high-risk and secondary prevention. Circulation. 2003;107:2059-2065.
29. Hense HW, Schulte H, Lowel H, et al. Framingham risk function over-estimates risk of coronary heart disease in men and women from Germany: results from MONICA Augsburg and the PROCAM cohorts. Eur Heart J. 2003;24:1-9.